ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 67 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 22.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $1,598,000 | -28.4% | 598,443 | 0.0% | 0.02% | -31.4% |
| Q2 2014 | $2,232,000 | -68.3% | 598,443 | 0.0% | 0.04% | -69.3% |
| Q1 2014 | $7,038,000 | +40.4% | 598,443 | -0.5% | 0.11% | +16.3% |
| Q4 2013 | $5,014,000 | +21.1% | 601,154 | +34.6% | 0.10% | +4.3% |
| Q3 2013 | $4,141,000 | -5.2% | 446,758 | +0.2% | 0.09% | -7.8% |
| Q2 2013 | $4,368,000 | – | 445,698 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,368,500 | $3,134,000 | 0.61% |
| TANG CAPITAL MANAGEMENT LLC | 365,000 | $836,000 | 0.46% |
| Abingworth LLP | 603,740 | $1,352,000 | 0.38% |
| Cheyne Capital Management (UK) LLP | 150,000 | $338,000 | 0.09% |
| Telemetry Investments, L.L.C. | 50,000 | $114,000 | 0.07% |
| Rotella Capital Management, Inc. | 19,473 | $45,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 461,957 | $1,058,000 | 0.03% |
| Nine Chapters Capital Management LLC | 113,700 | $260,000 | 0.02% |
| STONERIDGE INVESTMENT PARTNERS LLC | 49,471 | $113,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 87,388 | $200,000 | 0.01% |